Pharmaceuticals responsible for CCG term future of the the Trust to evaluate implementation activities business. them. External advisers manufacturing unit, appointed. Outline implement the agreed business case is being restructuring of our prepared for pharmaceuticals consideration by the commercial activities to Trust. deliver a commercially Finalise product distribution Arrangements with specialist Review sales Products business viable business. agreements in retail optometry. wholesalers established revenues and profit achieved YTD against agreed sales revenues of business plan. £4,196K which were £739K or 15% below budget (£4,935) achieved YTD EBITDA of £198K which was £158K or 44% below of budget (£356K) Included in Trust financial reporting. Establish long term sales team Long term plans for activities Formal board review This will take place as plans for Ireland. in Ireland under review of position against part of the strategic following the rejection of business plan, and options review over the for the vast the longer term future next few months. majority of products of the business. Develop a business plan and Market opportunities reviewed review of new ophthalmic but no new ointment products ointment products. identified Review revenues and profit Products business against agreed business plan. achieved YTD revenues of £3,230K which were £173K or 5% below of budget (£3,403) achieved YTD EBITDA of £217K which was £97K or 31% below of budget (£314K) Board review of position against business plan.
Pharmaceuticals manufacturing unit, implement the agreed restructuring of our pharmaceuticals commercial activities to deliver a commercially viable business. responsible for CCG implementation activities term future of the business. the Trust to evaluate them. External advisers appointed. Outline business case is being prepared for consideration by the Trust. Finalise product distribution agreements in retail optometry. Arrangements with specialist wholesalers established Review sales revenues and profit against agreed business plan. Products business achieved YTD sales revenues of £4,196K which were £739K or 15% below budget (£4,935) achieved YTD EBITDA of £198K which was £158K or 44% below of budget (£356K) Included in Trust financial reporting. Establish long term sales team plans for Ireland. Long term plans for activities in Ireland under review following the rejection of for the vast majority of products Formal board review of position against business plan, and the longer term future of the business. This will take place as part of the strategic options review over the next few months. Develop a business plan and review of new ophthalmic ointment products. Market opportunities reviewed but no new ointment products identified Review revenues and profit against agreed business plan. Board review of position against business plan. Products business achieved YTD revenues of £3,230K which were £173K or 5% below of budget (£3,403) achieved YTD EBITDA of £217K which was £97K or 31% below of budget (£314K)
Item%207%20-%20Board%201516%20corporate%20priorities%20Q3Q4%20update.docx